ConocoPhillips
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-21 18:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 10-Q | 2026-11-05 | Read on SEC.gov |
| 8-K | 2026-11-05 | Read on SEC.gov |
| 8-K | 2026-08-11 | Read on SEC.gov |
| 10-Q | 2026-08-06 | Read on SEC.gov |
| 8-K | 2026-08-06 | Read on SEC.gov |
| 8-K | 2026-06-23 | Read on SEC.gov |
| 8-K | 2026-05-14 | Read on SEC.gov |
| 10-Q | 2026-04-30 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-21 14:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $51.82B | Annual | 2025-12-31 | 2026-02-17 | 10-K |
| Net income | $7.99B | Annual | 2025-12-31 | 2026-02-17 | 10-K |
| Operating cash flow | $19.80B | Annual | 2025-12-31 | 2026-02-17 | 10-K |
| Total assets | $121.94B | As of | 2025-12-31 | 2026-02-17 | 10-K |
| Total liabilities | $57.45B | As of | 2025-12-31 | 2026-02-17 | 10-K |
| Stockholders’ equity | $64.49B | As of | 2025-12-31 | 2026-02-17 | 10-K |
| Cash and cash equivalents | $6.50B | As of | 2025-12-31 | 2026-02-17 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 3.30, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.67% YoY
Margins
- Gross margin
- 25.09%
- Operating margin
- 19.24%
- Net margin
- 13.51%
Key ratios & quality
- Enterprise valuei
- 176.91B
- Altman Z-Scorei
- 3.30
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 36.42B | 32.57B | 18.78B | 45.83B | 78.49B | 56.14B | 54.75B | 58.94B |
| Gross profit | 10.95B | 9.31B | 841.00M | 14.77B | 30.01B | 18.20B | 16.38B | 14.79B |
| Selling & admin expenses | 401.00M | 556.00M | 430.00M | 719.00M | 623.00M | 705.00M | 1.16B | 893.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 9.14B | 7.06B | -1.80B | 12.07B | 25.46B | 15.03B | 12.78B | 11.34B |
| Pretax profit | 9.97B | 9.52B | -3.14B | 12.71B | 28.23B | 16.29B | 13.67B | 12.66B |
| Tax | 3.67B | 2.27B | -485.00M | 4.63B | 9.55B | 5.33B | 4.43B | 4.67B |
| Net profit | 6.31B | 7.26B | -2.66B | 8.08B | 18.68B | 10.96B | 9.25B | 7.99B |
| Basic EPS | 5 | 6 | -3 | 6 | 15 | 9 | 8 | 6 |
| Diluted EPS | 5.32 | 6.40 | -2.51 | 6.07 | 14.57 | 9.06 | 7.81 | 6.35 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 14.00B | 15.03B | 13.39B | 15.76B | 19.16B | 19.44B |
| Gross profit | 3.51B | 3.63B | 2.58B | 4.30B | 7.04B | 6.57B |
| Selling & admin expenses | 250.00M | 271.00M | 181.00M | 193.00M | 188.00M | 219.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.61B | 2.76B | 1.76B | 3.39B | 5.98B | 5.64B |
| Pretax profit | 3.02B | 2.93B | 2.25B | 3.36B | 6.08B | 5.98B |
| Tax | 1.05B | 1.20B | 803.00M | 1.18B | 2.15B | 1.98B |
| Net profit | 1.97B | 1.73B | 1.44B | 2.18B | 3.93B | 4.00B |
| Basic EPS | 2 | 1 | 1 | 2 | 3 | 3 |
| Diluted EPS | 1.56 | 1.38 | 1.17 | 1.78 | 3.23 | 3.34 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 13.27B | 16.91B | 12.07B | 16.05B | 18.75B | 14.33B | 15.65B | 15.53B |
| Cash & ST investments | 7.63B | 10.23B | 7.86B | 6.59B | 9.24B | 6.61B | 6.11B | 6.98B |
| Inventory | 1.01B | 1.03B | 1.00B | 1.21B | 1.22B | 1.40B | 1.81B | 1.87B |
| Total assets | 69.98B | 70.51B | 62.62B | 90.66B | 93.83B | 95.92B | 122.78B | 121.94B |
| Total current liabilities | 7.40B | 7.04B | 5.37B | 12.02B | 12.85B | 10.01B | 12.12B | 11.97B |
| Short-term debt | 112.00M | 105.00M | 619.00M | 1.20B | 417.00M | 1.07B | 1.04B | 1.02B |
| Long-term debt | 14.86B | 14.16B | 14.03B | 17.75B | 15.19B | 17.03B | 22.64B | 21.93B |
| Total liabilities | 37,916,000,000.00 | 35,464,000,000.00 | 32,769,000,000.00 | 45,255,000,000.00 | 45,826,000,000.00 | 46,645,000,000.00 | 57,984,000,000.00 | 57,452,000,000.00 |
| Total equity | 32.06B | 35.05B | 29.85B | 45.41B | 48.00B | 49.28B | 64.80B | 64.49B |
| Retained earnings | 34.01B | 39.74B | 35.21B | 40.67B | 53.03B | 59.27B | 64.87B | 68.86B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 13.94B | 15.88B | 15.53B | 16.23B | 19.20B | 20.87B |
| Cash & ST investments | 5.34B | 6.26B | 6.98B | 6.36B | 7.69B | 9.93B |
| Inventory | 1.90B | 1.72B | 1.87B | 1.91B | 1.88B | 1.98B |
| Total assets | 122.60B | 122.47B | 121.94B | 122.73B | 124.26B | 126.07B |
| Total current liabilities | 10.99B | 12.01B | 11.97B | 12.59B | 12.45B | 13.75B |
| Short-term debt | 414.00M | 1.02B | 1.02B | 1.07B | 462.00M | 878.00M |
| Long-term debt | 23.12B | 22.47B | 21.93B | 22.26B | 22.83B | 22.38B |
| Total liabilities | 57,027,000,000.00 | 57,549,000,000.00 | 57,452,000,000.00 | 58,184,000,000.00 | 58,912,000,000.00 | 60,082,000,000.00 |
| Total equity | 65.57B | 64.92B | 64.49B | 64.54B | 65.35B | 65.99B |
| Retained earnings | 67.71B | 68.46B | 68.86B | 70.02B | 72.92B | 75.92B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 12.93B | 11.10B | 4.80B | 17.00B | 28.31B | 19.97B | 20.12B | 19.80B |
| Depreciation & amortization | 5.96B | 6.09B | 5.52B | 7.25B | 7.84B | 8.43B | 9.65B | 11.68B |
| Free cash flow | 6.18B | 4.47B | 87.00M | 11.67B | 18.16B | 8.72B | 8.01B | 7.24B |
| Dividends paid | -1.36B | -1.50B | -1.83B | -2.36B | -5.73B | -5.58B | -3.65B | -4.00B |
| Stock buybacks / issuance | -2.88B | -3.53B | -897.00M | -3.48B | -8.91B | -5.45B | -5.54B | -5.12B |
| Ending cash balance | 6.15B | 5.36B | 3.32B | 5.40B | 6.69B | 5.90B | 5.91B | 6.92B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 3.49B | 5.88B | 4.32B | 4.30B | 7.43B | 7.20B |
| Depreciation & amortization | 2.84B | 2.92B | 3.18B | 2.91B | 2.98B | 3.01B |
| Free cash flow | 199.00M | 3.01B | 1.30B | 1.35B | 4.41B | 4.06B |
| Dividends paid | -984.00M | -975.00M | -1.04B | -1.03B | -1.03B | -1.01B |
| Stock buybacks / issuance | -1.23B | -1.28B | -1.06B | -1.04B | -2.00B | -2.41B |
| Ending cash balance | 5.23B | 5.60B | 6.92B | 6.25B | 6.97B | 8.22B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 20.01 | 21.49 | -8.33 | 21.47 | 39.87 | 22.45 | 16.16 | 12.32 |
| ROA %i | 8.73 | 10.23 | -4.06 | 10.54 | 20.19 | 11.51 | 8.43 | 6.51 |
| ROIC %i | 14.16 | 16.33 | -3.98 | 15.87 | 29.53 | 17.10 | 12.32 | 9.65 |
| 5-year avg ROE %i | 2.26 | 3.91 | 4.17 | 10.39 | 18.89 | 19.38 | 18.31 | 22.44 |
| EBIT margin %i | 30.37 | 32.63 | -11.08 | 30.20 | 37.31 | 30.91 | 27.00 | 23.56 |
| FCF / sales %i | 16.98 | 13.72 | 0.46 | 25.47 | 23.13 | 15.53 | 14.62 | 12.29 |
| Current ratioi | 1.79 | 2.40 | 2.25 | 1.34 | 1.46 | 1.43 | 1.29 | 1.30 |
| Quick ratioi | 1.58 | 1.93 | 1.98 | 1.10 | 1.27 | 1.21 | 1.06 | 1.07 |
| Debt / assetsi | 21.39 | 21.12 | 24.54 | 21.99 | 17.74 | 19.74 | 19.81 | 19.23 |
| LT debt / equityi | 46.51 | 42.28 | 49.42 | 41.26 | 33.80 | 36.25 | 35.94 | 34.77 |
| Interest coveragei | 10.17 | 9.63 | -1.97 | 12.29 | 27.76 | 16.32 | 13.34 | 11.26 |
| Revenue CAGR (3Y) %i | 7.20 | 11.19 | -13.58 | 7.96 | 34.08 | 44.04 | 6.11 | -9.11 |
| Net income CAGR (3Y) %i | -- | -- | -- | 8.89 | 37.48 | -- | 4.60 | -24.66 |
| FCF CAGR (3Y) %i | -- | -- | -67.29 | 23.58 | 59.57 | 364.46 | -11.81 | -26.38 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 15.88 | 15.37 | 12.32 | 11.25 | 14.14 | 17.60 |
| ROA %i | 8.38 | 8.05 | 6.51 | 5.91 | 7.50 | 9.27 |
| ROIC %i | 12.65 | 12.30 | 9.65 | 9.13 | 11.26 | 13.78 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 25.71 | 24.42 | 23.56 | 21.97 | 24.94 | 27.72 |
| FCF / sales %i | 11.98 | 11.86 | 12.29 | 10.06 | 15.89 | 16.40 |
| Current ratioi | 1.27 | 1.32 | 1.30 | 1.29 | 1.54 | 1.52 |
| Quick ratioi | 1.01 | 1.00 | 1.07 | 1.07 | 1.18 | 1.30 |
| Debt / assetsi | 19.19 | 19.17 | 19.23 | 19.01 | 18.74 | 18.45 |
| LT debt / equityi | 35.25 | 34.60 | 34.77 | 34.49 | 34.93 | 33.92 |
| Interest coveragei | 12.69 | 11.98 | 11.26 | 10.40 | 13.36 | 16.96 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 20:02:42 · For reference only, not investment advice and not tailored to your situation.
ConocoPhillips discussion 0 comments